Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
immunology assays such as spectral flow cytometry, ELISA, immunofluorescence imaging preferred. The successful candidate should have a PhD in immunology and at least 5 years of postdoctoral experience and 2
-
, and validation of immunoassays (such as ELISA) and the evaluation or implementation of point-of-care diagnostic testing modalities to translate laboratory discoveries into scalable, translational public
-
agencies, investors, pharma companies etc. This role may also provide the opportunity to join a spin-out company as part of the founding team. Learn more about the innovative work here: https
-
be applied for efficient mapping of glycan-protein binding events or antibody characterization. Antibody titer determinations will be made using ELISA. The initial part of the project relies heavily
-
detection systems. You will apply various analytical techniques, including immunoassays using technologies such as Luminex, Surface Plasmon Resonance (SPR), ELISAs, electrochemical methods, and lateral flow
-
required. Experience with protein biochemistry (e.g., ELISA, Western blot, immunoisolation) or nucleic acid techniques (e.g. FISH, real-time PCR) is advantageous but not required. Experience with imaging
-
Technologies * Knowledge of laboratory safety standards and biosafety practices * Proficiency in molecular and cellular biology techniques, including microplate-based assays (e.g., ELISA, Oligreen siRNA assays
-
: A postdoctoral position is available in the Chaudhuri lab within the Nora Eccles Harrison Cardiovascular Research and Training Institute (http://www.cvrti.utah.edu), at the University of Utah
-
the Faculty of Medical Sciences here: https://www.ncl.ac.uk/medical-sciences/ Key Accountabilites To be responsible for day-to-day management and support of experimental work involving human and mouse
-
-based and molecular biology assays including qPCR, ELISA, high-content imaging, and next-generation sequencing (NGS). · Develop and utilize 2D/3D cell culture systems, including patient-derived